All lobbying filings

BALLARD PARTNERS

BALLARD PARTNERS filed a Q3 report for PRAXIS PRECISION MEDICINES, INC. on October 18, 2026, reporting $120,000 in lobbying income.

Lobbying for PRAXIS PRECISION MEDICINES, INC. · Biopharmaceutical company

All filings by BALLARD PARTNERS · Everything PRAXIS PRECISION MEDICINES, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 18, 2026

Income

$120,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 1

Food & Drug Administration (FDA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Engagement and strategy for the FDA and HHS related to product pipeline.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.